ST
VRTX icon

Spot Trading’s Vertex Pharmaceuticals VRTX Stock Holding History

Spot Trading’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3.33M Sell
21,900
-3,000
-12% -$452K 0.06% 464
2017
Q2 		$3.21M Buy
24,900
+16,100
+183% +$1.94M 0.06% 399
2017
Q1 		$962K Buy
+8,800
New +$775K 0.03% 770
2016
Q1 		– Sell
-13,600
Closed -$1.71M – 4019
2015
Q4 		$1.71M Sell
13,600
-800
-6% -$96.6K 0.02% 1123
2015
Q3 		$1.5M Sell
14,400
-19,200
-57% -$2.47M 0.01% 1285
2015
Q2 		$4.15M Buy
33,600
+16,900
+101% +$2.13M 0.04% 672
2015
Q1 		$1.97M Sell
16,700
-192,200
-92% -$23M 0.02% 1130
2014
Q4 		$24.8M Sell
208,900
-10,100
-5% -$1.14M 0.16% 124
2014
Q3 		$24.6M Sell
219,000
-70,500
-24% -$6.71M 0.12% 176
2014
Q2 		$27.4M Buy
289,500
+75,600
+35% +$5.3M 0.13% 143
2014
Q1 		$15.1M Buy
213,900
+15,100
+8% +$1.2M 0.08% 268
2013
Q4 		$14.8M Buy
198,800
+104,800
+111% +$7.3M 0.08% 269
2013
Q3 		$7.13M Sell
94,000
-28,200
-23% -$2.24M 0.04% 525
2013
Q2 		$9.78M Buy
+122,200
New +$9M 0.06% 375

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Spot Trading's VRTX Position: Q3 2017 in Review

Spot Trading increased its Vertex Pharmaceuticals (VRTX) stake by 58% in Q3 2017, buying an estimated $1.61M and bringing the position to 29,281 shares worth $4.45M. The position accounts for 0.08% of the portfolio, ranked #320.

Spot Trading first reported a position in VRTX in Q2 2013 and has held it in 14 quarters since. The position peaked at $9.71M in Q2 2013. 611 funds tracked by Wall St. Rank hold VRTX as of Q3 2017.

  • Spot Trading held 29,281 shares of Vertex Pharmaceuticals worth $4.45M as of Q3 2017.
  • Spot Trading bought 10,728 Vertex Pharmaceuticals shares in Q3 2017, an estimated $1.61M.
  • Vertex Pharmaceuticals made up 0.08% of Spot Trading's portfolio in Q3 2017, its #320 holding.
  • Spot Trading first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • Spot Trading's Vertex Pharmaceuticals position peaked at $9.71M in Q2 2013.
  • 611 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.